• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
CAL101

CAL101

Product ID C0044
Cas No. 870281-82-6
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $46.70 In stock
5 mg $100.40 In stock
10 mg $180.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

CAL101 is an inhibitor of p110δ PI3K that is clinically used to treat leukemias such as mantle cell lymphoma and chronic lymphocytic leukemia (CLL). CAL101 exhibits anticancer chemotherapeutic and immunosuppressive activities. In mantle cell lymphoma cells, CAL101 induces G1 phase cell cycle arrest and apoptosis. In non-Hodgkin lymphoma and CLL cells, CAL101 inhibits downstream phosphorylation of Akt and induces apoptosis. Additionally, this compound inhibits cell chemotaxis, decreases chemokine production, inhibits migration, and prevents ERK- and Akt-dependent B-cell receptor signaling in CLL cells.

Product Info

Cas No.

870281-82-6

Purity

≥98%

Formula

C22H18FN7O

Formula Wt.

415.42

IUPAC Name

5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one

Synonym

Idelalisib, GS1101, CAL-101

Solubility

DMSO 83 mg/mL warmed (199.79 mM) Ethanol 23 mg/mL (55.36 mM) Water Insoluble

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

C0044 MSDS PDF

Info Sheet

C0044 Info Sheet PDF

Brochures

PI3K-Akt-mTORC Pathway Booklet

References

Sanford DS, Wierda WG, Burger JA, et al. Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab into Clinical Practice. Clin Lymphoma Myeloma Leuk. 2015 Feb 19. [Epub ahead of print]. PMID: 25817936.

Chiron D, Martin P, Di Liberto M, et al. Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1. Cell Cycle. 2013 Jun 15;12(12):1892-900. PMID: 23676220.

Meadows SA, Vega F, Kashishian A, Johnson D, et al. PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma. Blood. 2012 Feb 23;119(8):1897-900. PMID: 22210877.

Hoellenriegel J, Meadows SA, Sivina M, et al. The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood. 2011 Sep 29;118(13):3603-12. PMID: 21803855.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S0269

    SAR245409

    Pyridopyrimidinone; PI3K and mTOR inhibitor.
    ≥96%
  • X1854

    p-Xyleneselenocyanate

    Synthetic derivative of selenocyanate.
    ≥99%
  • Z161023

    β-Zearalanol

    β-Zearalanol is a mycotoxin that has structural s...
    ≥98%
  • E6996

    Erythromycin Thiocyanate

    Macrolide; protein translation inhibitor, mammalia...
    ≥90%
  • A4002

    AK-7

    SIRT2 inhibitor.
    ≥98%
  • U6957

    Urotensin I

    Endogenous peptide, involved in stress signaling; ...
    ≥95%
  • T5672

    Tosufloxacin Tosylate

    Fluoroquinolone; topoisomerase IV and bacterial DN...
    ≥98%
  • G8104

    Guanylin, rat/mouse

    Endogenous peptide hormone; guanyl cyclase C agoni...
    ≥95%
  • T1679

    Tetracycline Hydrochloride

    Polyketide; protein translation inhibitor, mammali...
    ≥96%
  • P2918

    Phenylethyl-4-methylcaffeate

    Derivative of methyl caffeate, hydroxycinnamic aci...
    ≥98%
  • T1855

    Tentoxin

    Cyclic peptide mycotoxin produced by Alternaria; C...
    ≥98%, HPLC
  • S6018

    Spectinomycin Dihydrochloride Pentahydrate

    Aminocyclitol; protein synthesis inhibitor.
    ≥603 µg/mg (potency)
  • S0830

    R-(+)-Schisandrin A

    Found in Schisandra.
    ≥98%
  • S0254

    Sanguinarine Chloride

    Decreases expression of MMPs, PGE2, and COX-2, and...
    ≥98%
  • C4800

    CM346 Hydrochloride

    Potential anxiolytic.
    ≥99%
  • D1720

    Deferiprone

    Iron chelator.
    ≥99%
  • V3454

    Vinleurosine Sulfate

    Alkaloid found in Catharanthus.
    ≥95%
  • E537334

    Enniatin B

    Mycotoxin contaminant found in cereal grains.
    ≥99%
  • M4100

    MK-0524

    DP1 antagonist.
    ≥99%
  • E6232

    (−)-Epicatechin Gallate

    Flavanol originally found in Camilla (green tea); ...
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only